| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K34222889 |
| PharmacoGx | BRD-K34222889 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAF5 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | PATZ1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | ZNF709 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | SPRYD7 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-08 |
| mRNA | C16orf59 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | EP400 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | ZNF292 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | TCERG1L | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | FANCF | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
